Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Remnant lipoproteins

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Apolipoprotein M/sphingosine-1-phosphate: novel effects on lipids, inflammation and kidney biology

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Relation between plasma and brain lipids

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Using human genetics to predict the effects and side-effects of drugs

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Novel genes in LDL metabolism--a comprehensive overview

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Apolipoprotein M in lipid metabolism and cardiometabolic diseases

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Shared heritability and functional enrichment across six solid cancers

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prevalence and risk factors of prolonged QT interval and electrocardiographic abnormalities in persons living with HIV

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Publisher Correction: Shared heritability and functional enrichment across six solid cancers

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Impact of LDL cholesterol on microvascular versus macrovascular disease: A Mendelian Randomization Study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

PURPOSE OF REVIEW: To review recent advances in the field of remnant lipoproteins and remnant cholesterol with a focus on cardiovascular disease risk.

RECENT FINDINGS: In line with previous years' research, current observational, genetic, and mechanistic studies find remnant lipoproteins (defined in different ways) to be involved in atherosclerosis development and cardiovascular disease risk. High concentrations of remnant cholesterol could explain some of the residual risk of cardiovascular disease seen after LDL cholesterol lowering. This will be increasingly important as populations worldwide become more obese and more have diabetes, both of which elevate remnant cholesterol concentrations. Many smaller scale studies and post hoc analyses show that remnant cholesterol can be lowered by different types of drugs; however, results from large scale studies with the primary aim of reducing cardiovascular disease risk through lowering of remnant cholesterol in individuals with elevated concentrations are still missing, although some are under way.

SUMMARY: Remnant cholesterol is a risk factor for cardiovascular disease, and can be lowered by different types of drugs; however, large scale studies of cardiovascular disease risk reduction through remnant lipoprotein lowering are under way.

Original languageEnglish
JournalCurrent Opinion in Lipidology
Volume28
Issue number4
Pages (from-to)300-307
Number of pages8
ISSN0957-9672
DOIs
Publication statusPublished - Aug 2017

    Research areas

  • Journal Article

ID: 52336335